1. Home
  2. PATH vs LGND Comparison

PATH vs LGND Comparison

Compare PATH & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UiPath Inc.

PATH

UiPath Inc.

SELL

Current Price

$12.39

Market Cap

7.3B

Sector

Technology

ML Signal

SELL

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

SELL

Current Price

$293.92

Market Cap

6.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PATH
LGND
Founded
2005
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
6.2B
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
PATH
LGND
Price
$12.39
$293.92
Analyst Decision
Hold
Strong Buy
Analyst Count
20
11
Target Price
$15.41
★ $361.27
AVG Volume (30 Days)
★ 22.4M
174.8K
Earning Date
12-03-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
500.00
★ 2886.36
EPS
0.11
★ 0.31
Revenue
★ $1,610,572,000.00
$141,102,000.00
Revenue This Year
$11.28
$8.82
Revenue Next Year
$8.25
$31.67
P/E Ratio
★ $119.55
$973.03
Revenue Growth
12.65
★ 29.48
52 Week Low
$9.20
$175.89
52 Week High
$19.84
$326.63

Technical Indicators

Market Signals
Indicator
PATH
LGND
Relative Strength Index (RSI) 39.17 40.60
Support Level $10.58 $280.42
Resistance Level $13.33 $294.00
Average True Range (ATR) 0.49 12.15
MACD -0.05 -2.20
Stochastic Oscillator 8.92 1.10

Price Performance

Historical Comparison
PATH
LGND

About PATH UiPath Inc.

UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: